Referanslar

• Akhmanova, A., & Steinmetz, M. O. (2008). Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nature reviews Molecular cell biology, 9(4), 309-322. google scholar
• An, W., Wang, W., Yu, T., Zhang, Y., Miao, Z., Meng, T., & Shen, J. (2016). Discovery of novel 2-phenyl-imidazo [1, 2-a] pyridine ana-logues targeting tubulin polymerization as antiproliferative agents. European Journal of Medicinal Chemistry, 112, 367-372. google scholar
• Aponte, P. M., & Caicedo, A. (2017). Stemness in cancer: stem cells, cancer stem cells, and their microenvironment. Stem cells inter-national, 2017(1), 5619472. google scholar
• Bagdi, A. K., Santra, S., Monir, K., & Hajra, A. (2015). Synthesis of imidazo [1, 2-a] pyridines: a decade update. Chemical Communi-cations, 51(9), 1555-1575. google scholar
• Brown, J. S., Amend, S. R., Austin, R. H., Gatenby, R. A., Hammar-lund, E. U., & Pienta, K. J. (2023). Updating the definition of cancer. Molecular Cancer Research, 21(11), 1142-1147. google scholar
• Chu, C. S., & Rubin, S. C. (2018). Basic principles of chemotherapy. In Clinical gynecologic oncology (pp. 449-469). Elsevier. google scholar
• DeVita, V. T., Lawrence, T. S., & Rosenberg, S. A. (2008). DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncol-ogy (Vol. 2). Lippincott Williams & Wilkins. google scholar
• Dumontet, C., & Jordan, M. A. (2010). Microtubule-binding agents: a dynamic field of cancer therapeutics. Nature reviews Drug dis-covery, 9(10), 790-803. google scholar
• Elseginy, S. A., Oliveira, A. S. F., Shoemark, D. K., & Sessions, R. B. (2022). Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking. RSC medicinal chemistry, 13(8), 929-943. google scholar
• Field, J. J., Kanakkanthara, A., & Miller, J. H. (2014). Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. Bioorganic & medicinal chemistry, 22(18), 5050-5059. google scholar
• Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvo-gel, L., & Kroemer, G. (2007). Cell death modalities: classification and pathophysiological implications. Cell Death & Differentia-tion, 14(7), 1237-1243. google scholar
• Güçlü, D., Kuzu, B., Tozlu, İ., Taşpınar, F., Canpınar, H., Taşpınar, M., & Menges, N. (2018). Synthesis of novel imidazopyridines and their biological evaluation as potent anticancer agents: A promising candidate for glioblastoma. Bioorganic & Medicinal Chemistry Letters, 28(15), 2647-2651. google scholar
• Guo, H., Li, X., Guo, Y., & Zhen, L. (2019). An overview of tubulin modulators deposited in protein data bank. Medicinal Chemistry Research, 28, 927-937. google scholar
• Howard, J., & Hyman, A. A. (2003). Dynamics and mechanics of the microtubule plus end. Nature, 422(6933), 753-758. google scholar
• Jordan, M. A. (2002). Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Current Medicinal Chemistry-Anti-Cancer Agents, 2(1), 1-17. google scholar
• Jordan, M. A., & Wilson, L. (2004). Microtubules as a target for anticancer drugs. Nature reviews cancer, 4(4), 253-265. google scholar
• Kamal, A., Kumar, G. B., Nayak, V. L., Reddy, V. S., Shaik, A. B., & Reddy, M. K. (2015). Design, synthesis and biological evaluation of imidazopyridine/imidazopyrimidine-benzimidazole conjugates as potential anticancer agents. Medicinal Chemistry Communica-tions, 6(4), 606-612. google scholar
• Kamal, A., Rao, A. S., Nayak, V. L., Reddy, N. S., Swapna, K., Ra-makrishna, G., & Alvala, M. (2014). Synthesis and biological evaluation of imidazo [1, 5-a] pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway. Organic & Biomolecular Chemistry, 12(48), 9864-9880. google scholar
• Kamal, A., Reddy, J. S., Ramaiah, M. J., Dastagiri, D., Bharathi, E. V., Sagar, M. V. P., ... & Pal-Bhadra, M. (2010). Design, syn-thesis and biological evaluation of imidazopyridine/pyrimidine-chalcone derivatives as potential anticancer agents. Medicinal Chemistry Communications, 1(5), 355-360. google scholar
• Kamal, A., Reddy, V. S., Karnewar, S., Chourasiya, S. S., Shaik, A. B., Kumar, G. B., ... & Kotamraju, S. (2013). Synthesis and Biological Evaluation of Imidazopyridine-Oxindole Conjugates as Microtubule-Targeting Agents. ChemMedChem, 8(12), 20152025. google scholar
• Kaur, R., Kaur, G., Gill, R. K., Soni, R., & Bariwal, J. (2014). Recent developments in tubulin polymerization inhibitors: an overview. European Journal of Medicinal Chemistry, 87, 89-124. google scholar
• Kendall, J. D., Rewcastle, G. W., Frederick, R., Mawson, C., Denny, W. A., Marshall, E. S., ... & Shepherd, P. R. (2007). Synthesis, bio-logical evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110 inhibitors. Bioorganic & Medicinal Chem-istry, 15(24), 7677-7687. google scholar
• Khatun, S., Singh, A., Bader, G. N., & Sofi, F. A. (2022). Imida-zopyridine, a promising scaffold with potential medicinal applica-tions and structural activity relationship (SAR): recent advances. Journal of Biomolecular Structure and Dynamics, 40(24), 1427914302. google scholar
• Kim, O., Jeong, Y., Lee, H., Hong, S. S., & Hong, S. (2011). De-sign and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis. Journal of Medicinal Chemistry, 54(7), 2455-2466. google scholar
• Li, D. D., Qin, Y. J., Zhang, X., Yin, Y., Zhu, H. L., & Zhao, L. G. (2015). Combined molecular docking, 3D-QSAR, and pharma-cophore model: design of novel tubulin polymerization inhibitors by binding to colchicine-binding site. Chemical Biology & Drug Design, 86(4), 731-745. google scholar
• Lippert III, J. W. (2007). Vascular disrupting agents. Bioorganic & Medicinal Chemistry, 15(2), 605-615. google scholar
• Liu, J., Zuo, D., Jing, T., Guo, M., Xing, L., Zhang,W., ... Zhai, X. (2017). Synthesis, biological evaluation and molecular model-ing of imidazo [1, 2-a] pyridine derivatives as potent antitubulin agents. Bioorganic & Medicinal Chemistry, 25(15), 4088-4099. google scholar
• Lu, Y., Chen, J., Xiao, M., Li, W., & Miller, D. D. (2012). An overview of tubulin inhibitors that interact with the colchicine binding site. Pharmaceutical research, 29, 2943-2971. google scholar
• Martmez-Urbina, M. A., Zentella, A., Vilchis-Reyes, M. A., Guzman, Â., Vargas, O., Apan, M. T. R.,... & D^az, E. (2010). 6-Substituted 2-(N-trifluoroacetylamino) imidazopyridines induce cell cycle ar-rest and apoptosis in SK-LU-1 human cancer cell line. European Journal of Medicinal Chemistry, 45(3), 1211-1219. google scholar
• Meng, T., Zhang, Z., Hu, D., Lin, L., Ding, J., Wang, X., & Shen, J. (2007). Three-Component Combinatorial Synthesis of a Substi-tuted 6 H-Pyrido [2 ‘, 1 ‘: 2, 3] imidazo-[4, 5-c] isoquinolin-5 (6 H)-one Library with Cytotoxic Activity. Journal of Combinatorial Chemistry, 9(5), 739-741. google scholar
• Moore, Sarah. (2020, February 06). What is Tubulin?. News-Medical. Retrieved on January 26, 2024 from https://www.news-medical. net/life-sciences/What-is-Tubulin.aspx. google scholar
• Nam, N. H. (2003). Combretastatin A-4 analogues as antimitotic anti-tumor agents. Current Medicinal Chemistry, 10(17), 1697-1722. google scholar
• Nogales, E., Whittaker, M., Milligan, R. A., & Downing, K. H. (1999). High-resolution model of the microtubule. Cell, 96(1), 79-88. google scholar
• Ohsumi, K., Nakagawa, R., Fukuda, Y., Hatanaka, T., Morinaga, Y., Nihei, Y., ... & Tsuji, T. (1998). Novel combretastatin analogues effective against murine solid tumors: design and structure activ-ity relationships. Journal of Medicinal Chemistry, 41(16), 30223032. google scholar
• Pragyandipta, P., Pedapati, R. K., Reddy, P. K., Nayek, A., Meher, R. K., Guru, S. K., ... & Naik, P. K. (2023). Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model. Chemico-Biological Interactions, 110606. google scholar
• Ramya, P. S., Guntuku, L., Angapelly, S., Digwal, C. S., Lakshmi, U. J., Sigalapalli, D. K., ... & Kamal, A. (2018). Synthesis and bio-logical evaluation of curcumin inspired imidazo [1, 2-a] pyridine analogues as tubulin polymerization inhibitors. European Journal of Medicinal Chemistry, 143, 216-231. google scholar
• Ravelli, R. B., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004). Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature, 428(6979), 198-202. google scholar
• Sanghai, N., Jain, V., Preet, R., Kandekar, S., Das, S., Trivedi, N., ... & Bharatam, P. V. (2014). Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin poly-merization inhibitors, antimitotic and anticancer agents. Med-ChemComm, 5(6), 766-782. google scholar
• Sayeed, I. B., Nayak, V. L., Shareef, M. A., Chouhan, N. K., & Kamal, A. (2017). Design, synthesis and biological evaluation of imi-dazopyridine-propenone conjugates as potent tubulin inhibitors. MedChemComm, 8(5), 1000-1006. google scholar
• Sayeed, I. B., Vishnuvardhan, M. V. P. S., Nagarajan, A., Kantevari, S., & Kamal, A. (2018). Imidazopyridine linked triazoles as tubulin inhibitors, effectively triggering apoptosis in lung cancer cell line. Bioorganic Chemistry, 80, 714-720. google scholar
• Schiff, P. B., Fant, J., & Horwitz, S. B. (1979). Promotion of micro-tubule assembly in vitro by taxol. Nature, 277(5698), 665-667. google scholar
• Shan, Y. S., Zhang, J., Liu, Z., Wang, M., & Dong, Y. (2011). Devel-opments of combretastatin A-4 derivatives as anticancer agents. Current Medicinal Chemistry, 18(4), 523-538. google scholar
• Sigalapalli, D. K., Kiranmai, G., Devi, G. P., Tokala, R., Sana, S., Tripura, C., ... & Tangellamudi, N. D. (2021). Synthesis and bi-ological evaluation of novel imidazo [1, 2-a] pyridine-oxadiazole hybrids as anti-proliferative agents: Study of microtubule poly-merization inhibition and DNA binding. Bioorganic & Medicinal Chemistry, 43, 116277. google scholar
• Sontag, C. A., Staley, J. T., & Erickson, H. P. (2005). In vitro assembly and GTP hydrolysis by bacterial tubulins BtubA and BtubB. The Journal of Cell Biology, 169(2), 233-238. google scholar
• Stroylov, V. S., Svitanko, I. V., Maksimenko, A. S., Kislyi, V. P., Semenova, M. N., & Semenov, V. V. (2020). Computational modeling and target synthesis of monomethoxy-substituted o-diphenylisoxazoles with unexpectedly high antimitotic micro-tubule destabilizing activity. Bioorganic & Medicinal Chemistry Letters, 30(23), 127608. google scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 71(3), 209-249. google scholar
• Swift, L. H., & Golsteyn, R. M. (2014). Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells. International Journal of Molecular Sciences, 15(3), 3403-3431. google scholar
• Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984). Adriamycin-induced DNA damage mediated by mam-malian DNA topoisomerase II. Science, 226(4673), 466-468. google scholar
• Thammathong, J., Chisam, K. B., Tessmer, G. E., Womack, C. B., Sidrak, M. M., Weissmiller, A. M., & Banerjee, S. (2023). Fused Imidazopyrazine-Based Tubulin Polymerization Inhibitors Inhibit Neuroblastoma Cell Function. ACS Medicinal Chemistry Letters, 14(9), 1284-1294. google scholar
• Tilsed, C. M., Fisher, S. A., Nowak, A. K., Lake, R. A., & Lesterhuis, W. J. (2022). Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Frontiers in Oncology, 12, 960317. google scholar
• Xi, J. B., Fang, Y. F., Frett, B., Zhu, M. L., Zhu, T., Kong, Y. N., ... & Hu, W. (2017). Structure-based design and synthesis of imidazo [1, 2-a] pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities. European Journal of Medicinal Chemistry, 126, 1083-1106. google scholar
• Zhang, Z., Meng, T., Yang, N., Wang, W., Xiong, B., Chen, Y., ... & Ding, J. (2011). MT119, a new planar-structured compound, tar-gets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation. International Journal of Cancer, 129(1), 214-224. google scholar

Atıflar